Dr. Marieann Brill | Forttuna Council Member

Skills

Regulatory Affairs & Medical Product Lifecycle Management Health Policy & Public Health Leadership Academic Leadership & Workforce Development

About

Dr. Marieann R. Brill, PhD, MBA, RAC, MLS(ASCP), is an accomplished leader in public health and regulatory science, bringing more than 20 years of experience across the U.S. Food and Drug Administration (FDA), the Department of Defense (DoD), and academic institutions. Her work has consistently focused on advancing the safety, effectiveness, and innovation of medical products, with deep expertise in regulatory affairs...

Company details

US Food and Drug Administration

Company Bio

The U.S. Food and Drug Administration (FDA) is a federal agency within the U.S. Department of Health and Human Services responsible for protecting and promoting public health. It regulates a wide range of products, including human and veterinary drugs, vaccines, medical devices, food, cosmetics, and tobacco products. The FDA ensures that these products are safe, effective, and accurately labeled, while also providing science-based information to help consumers make informed health decisions.

Through rigorous scientific evaluation, inspections, and regulatory oversight, the FDA plays a critical role in maintaining the integrity of the healthcare and food systems in the United States. It also supports innovation by facilitating the development of new medical products and responding to emerging public health challenges, including global health threats and supply chain risks. With a workforce of thousands of experts, the agency continues to uphold high standards of safety, quality, and transparency across industries that directly impact human health and well-being.

Published content

Articles yet to be published.

About

Dr. Brill currently serves in a senior leadership role at the FDA’s Center for Devices and Radiological Health, where she has held key positions including Deputy Office Director and Acting Office Director within the Office of Orthopedic Devices. In these roles, she has led complex regulatory decision-making across the full product lifecycle, shaping both U.S. policy and global regulatory practices. She has also played a pivotal role in developing regulatory frameworks for emerging technologies while fostering collaboration with industry and the scientific community.

Earlier in her career, Dr. Brill served as Associate Director for Regulatory Affairs in the Office of Pediatric Therapeutics, where she provided strategic leadership to support the advancement of pediatric medical products. She has also held roles as Branch Chief at the Center for Tobacco Products and as a Senior Regulatory Scientist supporting federal and military health programs, overseeing regulatory submissions, clinical trials, and compliance initiatives.

In addition to her government service, Dr. Brill contributes to academia as an Adjunct Lecturer, teaching regulatory management and quality systems while mentoring the next generation of healthcare and regulatory professionals. Her academic work reflects a strong commitment to education, curriculum development, and workforce advancement.

Dr. Brill holds a PhD in Public Health with a focus on Epidemiology, as well as an MBA in Healthcare Management. She is also a certified Regulatory Affairs professional (RAC) and a credentialed Medical Laboratory Scientist (MLS), underscoring her multidisciplinary expertise and leadership in the field.